Tag: pfizer pharmaceuticals stock
How a drug for Alzheimer’s disease may be cheaper than a $300 million blockbuster
Pfizer (PFE) reported its biggest quarterly profit in three years as the company reported its best-ever quarter and the blockbuster drug it was selling to treat the disease gained traction.The stock surged more than 3% to $8.75 per share.Analysts said the sales boost is partly due to Pfizer’s strategy of offering its products for a […]
Continue Reading...
How the US is making $300 million a day from its drug-making business
The US is on track to make $300m a day in revenue from drug sales this year from its pharmaceutical manufacturing sector, according to a report from the US Chamber of Commerce.Glenmark Pharmaceuticals, for example, reported that its sales of Pfizer’s cholesterol drug rivastigmine increased by nearly 30 per cent in the first quarter.Inovio Pharmaceuticals […]
Continue Reading...